Pharmafile Logo

How smart spaces and real-time strategy transformed ASCO® 2025

August 19, 2025 | Congress, Inizio, oncology 

- PMLiVE

Nick Bellomo, Director of Technology and Engagement, Inizio Medical

ASCO® 2025 wasn’t just about oncology breakthroughs – it was also a showcase for how technology is redefining congress engagement. Supporting dozens of clients with hundreds of deliverables, Inizio had a front-row seat to innovations that are reshaping how healthcare professionals (HCPs) learn and interact.

Highlights from the floor:

  • LED walls reimagined: Once static displays, LED walls are now interactive storytelling tools. From gesture-responsive MOAs to live trial dashboards, these experiences empowered HCPs to navigate content at their own pace, boosting engagement and driving more meaningful conversations.

  • Real-time in-booth analytics: Inizio piloted offline analytics that delivered live insights without internet dependency. This allowed brands to refine content mid-show, optimize staff alignment, and deliver more targeted education – all during the congress, not weeks later.

Why it matters:
These shifts mark a broader transformation: moving from passive storytelling to responsive engagement, and from delayed insights to real-time adaptability. For HCPs, this means richer, more relevant learning. For brands, it means smarter strategies and more impactful outcomes.

At Inizio, the booth is no longer just a backdrop – it’s a catalyst for strategic engagement and patient-focused progress.

Read the full article authored by Nick here. Discover more in the on-demand webinar Beyond the booth: Big ideas, smart spaces & strategic insights from ASCO® 2025.

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Video: Self-pay and Emerging Markets

A key feature of emerging markets is that patients often have to pay for a high proportion of their healthcare costs themselves. For all but the most severe conditions, public...

News: Therapy Watch HCV expands into 4 additional EU markets

The HCV market has been growing and changing remarkably quickly and with the development of new and improving drugs, the treatment of HCV has moved on in a short space...

News: Research Partnership launches new patient report – Living with Ulcerative Colitis

Living with UC is a quantitative study conducted online amongst 325 patients, including both adult and paediatric patients diagnosed with ulcerative colitis in 5 EU markets (France, Germany, Italy, Spain...

Summer Intern experience at Research Partnership

We look for bright and inquisitive people who want to learn in a company that's pushing the boundaries of pharmaceutical market research

Double win at Communiqué 2016: Pegasus scoops awards for Consultancy of the Year (for the second time!) and Excellence in Media Relations

Pegasus, an Ashfield company, part of UDG Healthcare plc, is delighted to have won the prestigious Consultancy of the Year award at the 2016 Communiqué Awards in London. The judges...

Beyond Andrology: Trends in Men’s Health in Emerging Markets

Published in eyeforpharma July 2016 by Rachel Howard

Pharma & life sciences division growth allows Pegasus to fill three new senior positions

Pegasus has expanded its pharma & life sciences senior team by appointing a new Associate Director and promoting two members of the existing team to Account Directors.

Infographic: HIV Market Snapshot

Our latest HIV infographic, taken from data collected from syndicated tracking study Therapy Watch, reveals that more than 3 in 5 naive or switch patients are currently treated with a STR (single...

Infographic: The vaccine opportunity in Asia

As predicted, the vaccine market in emerging and developing countries has continued to expand. While the global vaccine market is expected to grow at around 12% annually over the next...

Webinar: What next for biosimilars?

Tuesday 19th July 15:00 BST/10:00 EDT/16:00 CEST